Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Is a |
Carbidopa+levodopa+entacapone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Entacapone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Levodopa (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbidopa |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Entacapone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Entacapone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator value |
200 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbidopa |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Carbidopa |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator value |
25 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Levodopa (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Levodopa (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has presentation strength numerator value |
200 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Entacapone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Levodopa (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Entacapone (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Levodopa (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Is a |
Product containing carbidopa and entacapone and levodopa in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Carbidopa |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Count of base of active ingredient |
trois |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Is a |
Product containing only carbidopa and entacapone and levodopa in oral dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Plays role |
Antiparkinson therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Entacapone (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Carbidopa |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Carbidopa |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has basis of strength substance (attribute) |
Entacapone (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet |
Has precise active ingredient |
Levodopa (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|